Glooko is a digital health company focused on diabetes and glycemic management, and this weekly recap highlights its latest moves in data integration and strategic partnerships. Over the past week, the company emphasized new device connectivity and collaborations that deepen its role as a central data hub for diabetes care.
Glooko highlighted a new cloud-based integration with Tandem Diabetes Care’s t:slim X2 pump and Tandem Mobi system, allowing pump data to automatically flow into its platform after initial setup. This removes the need for manual uploads and cables, aiming to streamline data access for both patients and clinicians.
The Tandem integration is designed to make pump data available ahead of clinical visits, reducing time spent on data transfer and improving workflow efficiency for care teams. Such interoperability supports Glooko’s positioning in digital diabetes management, where integrated data streams are increasingly important for clinical adoption and scalability.
In a separate development, Glooko announced a partnership with mylife Diabetes Care that positions it as the primary data management provider for mylife products. The collaboration focuses on integrating data from multiple diabetes devices and digital tools to support treatment decision-making by care teams.
This mylife partnership suggests a deliberate strategy to grow through B2B integrations rather than relying solely on direct-to-consumer channels. If broadly adopted, it could expand Glooko’s user reach and data volume, key drivers for digital health platforms focused on chronic disease management.
Taken together, the Tandem cloud integration and mylife partnership signal a consistent push toward deeper ecosystem integration and workflow embedding. These moves are likely to enhance Glooko’s value proposition for providers and industry partners, reinforcing its competitive stance in connected diabetes care and supporting its long-term commercial prospects.


